<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Physiology and Medical Physics Articles</title>
<copyright>Copyright (c) 2013 Royal College of Surgeons in Ireland All rights reserved.</copyright>
<link>http://epubs.rcsi.ie/physiolart</link>
<description>Recent documents in Physiology and Medical Physics Articles</description>
<language>en-us</language>
<lastBuildDate>Sat, 26 Jan 2013 22:27:34 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Serum levels of pancreatic stone protein (PSP)/reg1A as an indicator of beta-cell apoptosis suggest an increased apoptosis rate in hepatocyte nuclear factor 1 alpha (HNF1A-MODY) carriers from the third decade of life onward.</title>
<link>http://epubs.rcsi.ie/physiolart/21</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/21</guid>
<pubDate>Mon, 30 Jul 2012 06:47:08 PDT</pubDate>
<description>
	<![CDATA[
	<p>ABSTRACT: BACKGROUND: Mutations in the transcription factor hepatocyte nuclear factor-1-alpha (HNF1A) result in the commonest type of maturity onset diabetes of the young (MODY). HNF1A-MODY carriers have reduced pancreatic beta cell mass, partially due to an increased rate of apoptosis. To date, it has not been possible to determine when apoptosis is occurring in HNF1A-MODY.We have recently demonstrated that beta cell apoptosis stimulates the expression of the pancreatic stone protein/regenerating (PSP/reg) gene in surviving neighbour cells, and that PSP/reg1A protein is subsequently secreted from these cells. The objective of this study was to determine whether serum levels of PSP/reg1A are elevated during disease progression in HNF1A-MODY carriers, and whether it may provide information regarding the onset of beta-cell apoptosis. METHODS: We analysed serum PSP/reg1A levels and correlated with clinical and biochemical parameters in subjects with HNF1A-MODY, glucokinase (GCK-MODY), and type 1 diabetes mellitus. A control group of normoglycaemic subjects was also analysed. RESULTS: PSP/reg1A serum levels were significantly elevated in HNF1A-MODY (n = 37) subjects compared to controls (n = 60) (median = 12.50 ng/ml, IQR = 10.61-17.87 ng/ml versus median = 10.72 ng/ml, IQR = 8.94-12.54 ng/ml, p = 0.0008). PSP/reg1A correlated negatively with insulin levels during OGTT, (rho = 0.40, p = 0.02). Interestingly we noted a significant positive correlation of PSP/reg1A with age of the HNF1A-MODY carriers (rho = 0.40 p = 0.02) with an age of 25 years separating carriers with low and high PSP/reg1A levels. Patients with type 1 diabetes mellitus also had elevated serum levels of PSP/reg1A compared to controls, however this was independent of the duration of diabetes. CONCLUSION: Our data suggest that beta cell apoptosis contributes increasingly to the pathophysiology of HNF1A-MODY in patients 25 years and over. PSP/reg1A may be developed as a serum marker to detect increased beta-cell apoptosis, or its therapeutic response.</p>

	]]>
</description>

<author>Siobhan Bacon et al.</author>


</item>






<item>
<title>SiteBinder: an improved approach for comparing multiple protein structural motifs.</title>
<link>http://epubs.rcsi.ie/physiolart/20</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/20</guid>
<pubDate>Tue, 12 Jun 2012 08:05:08 PDT</pubDate>
<description>
	<![CDATA[
	<p>There is a paramount need to develop new techniques and tools that will extract as much information as possible from the ever growing repository of protein 3D structures. We report here on the development of a software tool for the multiple superimposition of large sets of protein structural motifs. Our superimposition methodology performs a systematic search for the atom pairing that provides the best fit. During this search, the RMSD values for all chemically relevant pairings are calculated by quaternion algebra. The number of evaluated pairings is markedly decreased by using PDB annotations for atoms. This approach guarantees that the best fit will be found and can be applied even when sequence similarity is low or does not exist at all. We have implemented this methodology in the Web application SiteBinder, which is able to process up to thousands of protein structural motifs in a very short time, and which provides an intuitive and user-friendly interface. Our benchmarking analysis has shown the robustness, efficiency, and versatility of our methodology and its implementation by the successful superimposition of 1000 experimentally determined structures for each of 32 eukaryotic linear motifs. We also demonstrate the applicability of SiteBinder using three case studies. We first compared the structures of 61 PA-IIL sugar binding sites containing nine different sugars, and we found that the sugar binding sites of PA-IIL and its mutants have a conserved structure despite their binding different sugars. We then superimposed over 300 zinc finger central motifs and revealed that the molecular structure in the vicinity of the Zn atom is highly conserved. Finally, we superimposed 12 BH3 domains from pro-apoptotic proteins. Our findings come to support the hypothesis that there is a structural basis for the functional segregation of BH3-only proteins into activators and enablers.</p>

	]]>
</description>

<author>David Sehnal et al.</author>


</item>






<item>
<title>Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways.</title>
<link>http://epubs.rcsi.ie/physiolart/19</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/19</guid>
<pubDate>Tue, 12 Jun 2012 07:05:06 PDT</pubDate>
<description>
	<![CDATA[
	<p>Cannabis use confers a two-fold increase in risk for psychosis, with adolescent use conferring an even greater risk. A high-low activity polymorphism in catechol-O-methyltransferase (COMT), a gene encoding the COMT enzyme involved in dopamine clearance in the brain, may interact with adolescent cannabis exposure to increase risk for schizophrenia. The impact of such an interaction on central neurotransmitter pathways implicated in schizophrenia is unknown. Male mice with knockout of the COMT gene were treated chronically with delta-9-tetrahydrocannabinol (THC) during adolescence (postnatal day 32-52). We measured the size and density of GABAergic cells and the protein expression of cannabinoid receptor 1 (CB1R) in the prefrontal cortex (PFC) and hippocampus (HPC) in knockout mice relative to heterozygous mutants and wild-type controls. Size and density of dopaminergic neurons was also assessed in the ventral tegmental area (VTA) across the genotypes. COMT genotype × THC treatment interactions were observed for: (1) dopaminergic cell size in the VTA, (2) CB1R protein expression in the HPC, and (3) parvalbumin (PV) cell size in the PFC. No effects of adolescent THC treatment were observed for PV and dopaminergic cell density across the COMT genotypes. COMT genotype modulates the effects of chronic THC administration during adolescence on indices of neurotransmitter function in the brain. These findings illuminate how COMT deletion and adolescent cannabis use can interact to modulate the function of neurotransmitters systems implicated in schizophrenia.</p>

	]]>
</description>

<author>Aine T. Behan et al.</author>


</item>






<item>
<title>Full length Bid is sufficient to induce apoptosis of cultured rat hippocampal neurons.</title>
<link>http://epubs.rcsi.ie/physiolart/18</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/18</guid>
<pubDate>Mon, 12 Dec 2011 04:28:30 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Bcl-2 homology domain (BH) 3-only proteins are pro-apoptotic proteins of the Bcl-2 family that couple stress signals to the mitochondrial cell death pathways. The BH3-only protein Bid can be activated in response to death receptor activation via caspase 8-mediated cleavage into a truncated protein (tBid), which subsequently translocates to mitochondria and induces the release of cytochrome-C. Using a single-cell imaging approach of Bid cleavage and translocation during apoptosis, we have recently demonstrated that, in contrast to death receptor-induced apoptosis, caspase-independent excitotoxic apoptosis involves a translocation of full length Bid (FL-Bid) from the cytosol to mitochondria. We induced a delayed excitotoxic cell death in cultured rat hippocampal neurons by a 5-min exposure to the glutamate receptor agonist N-methyl-D-aspartate (NMDA; 300 microM).</p>
<p>RESULTS: Western blot experiments confirmed a translocation of FL-Bid to the mitochondria during excitotoxic apoptosis that was associated with the release of cytochrome-C from mitochondria. These results were confirmed by immunofluorescence analysis of Bid translocation during excitotoxic cell death using an antibody raised against the amino acids 1-58 of mouse Bid that is not able to detect tBid. Finally, inducible overexpression of FL-Bid or a Bid mutant that can not be cleaved by caspase-8 was sufficient to induce apoptosis in the hippocampal neuron cultures.</p>
<p>CONCLUSION: Our data suggest that translocation of FL-Bid is sufficient for the activation of mitochondrial cell death pathways in response to glutamate receptor overactivation.</p>

	]]>
</description>

<author>Hans-Georg König et al.</author>


<category>Animals</category>

<category>Animals, Newborn</category>

<category>Apoptosis</category>

<category>BH3 Interacting Domain Death Agonist Protein</category>

<category>Caspase 8</category>

<category>Cells, Cultured</category>

<category>Hippocampus</category>

<category>Mutant Proteins</category>

<category>Neurons</category>

<category>Neurotoxins</category>

<category>Peptide Hydrolases</category>

<category>Protein Transport</category>

<category>Rats</category>

<category>Rats, Inbred F344</category>

<category>Receptors, Glutamate</category>

</item>






<item>
<title>Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.</title>
<link>http://epubs.rcsi.ie/physiolart/17</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/17</guid>
<pubDate>Mon, 28 Nov 2011 04:24:04 PST</pubDate>
<description>
	<![CDATA[
	<p>Seven classes of mitogen-activated protein kinase (MAPK) intracellular signalling cascades exist, four of which are implicated in breast disease and function in mammary epithelial cells. These are the extracellular regulated kinase (ERK)1/2 pathway, the ERK5 pathway, the p38 pathway and the c-Jun N-terminal kinase (JNK) pathway. In some forms of human breast cancer and in many experimental models of breast cancer progression, signalling through the ERK1/2 pathway, in particular, has been implicated as being important. We review the influence of ERK1/2 activity on the organised three-dimensional association of mammary epithelial cells, and in models of breast cancer cell invasion. We assess the importance of epidermal growth factor receptor family signalling through ERK1/2 in models of breast cancer progression and the influence of ERK1/2 on its substrate, the oestrogen receptor, in this context. In parallel, we consider the importance of these MAPK-centred signalling cascades during the cycle of mammary gland development. Although less extensively studied, we highlight the instances of signalling through the p38, JNK and ERK5 pathways involved in breast cancer progression and mammary gland development.</p>

	]]>
</description>

<author>Jacqueline Whyte et al.</author>


<category>Animals</category>

<category>Breast Neoplasms</category>

<category>Disease Progression</category>

<category>Female</category>

<category>Humans</category>

<category>MAP Kinase Signaling System</category>

<category>Mammary Glands, Animal</category>

<category>Mammary Glands, Human</category>

<category>Mammary Neoplasms, Experimental</category>

<category>Mitogen-Activated Protein Kinase 1</category>

<category>Mitogen-Activated Protein Kinase 3</category>

</item>






<item>
<title>XIAP impairs Smac release from the mitochondria during apoptosis.</title>
<link>http://epubs.rcsi.ie/physiolart/16</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/16</guid>
<pubDate>Fri, 30 Sep 2011 04:38:46 PDT</pubDate>
<description>
	<![CDATA[
	<p>X-linked inhibitor of apoptosis protein (XIAP) is a potent inhibitor of caspases 3, 7 and 9, and mitochondrial Smac (second mitochondria-derived activator of caspase) release during apoptosis inhibits the activity of XIAP. In this study we show that cytosolic XIAP also feeds back to mitochondria to impair Smac release. We constructed a fluorescent XIAP-fusion protein by labelling NH(2)- and COOH-termini with Cerulean fluorescent protein (C-XIAP-C). Immunoprecipitation confirmed that C-XIAP-C retained the ability to interact with Smac and impaired extrinsically and intrinsically activated apoptosis in response to tumour necrosis factor-related apoptosis-inducing ligand/cycloheximide and staurosporine. In C-XIAP-C-expressing cells, cytochrome c release from mitochondria proceeded normally, whereas Smac release was significantly prolonged and incomplete. In addition, physiological expression of native XIAP prolonged or limited Smac release in HCT-116 colon cancer cells and primary mouse cortical neurons. The Smac-binding capacity of XIAP, but not caspase inhibition, was central for mitochondrial Smac retention, as evidenced in experiments using XIAP mutants that cannot bind to Smac or effector caspases. Similarly, the release of a Smac mutant that cannot bind to XIAP was not impaired by C-XIAP-C expression. Full Smac release could however be provoked by rapid cytosolic C-XIAP-C depletion upon digitonin-induced plasma membrane permeabilization. Our findings suggest that although mitochondria may already contain pores sufficient for cytochrome c release, elevated amounts of XIAP can selectively impair and limit the release of Smac.</p>

	]]>
</description>

<author>Lorna Flanagan et al.</author>


<category>Animals</category>

<category>Apoptosis</category>

<category>Carrier Proteins</category>

<category>Cell Membrane Permeability</category>

<category>Cell Proliferation</category>

<category>Cells, Cultured</category>

<category>Cytochromes c</category>

<category>Digitonin</category>

<category>Humans</category>

<category>Luminescent Proteins</category>

<category>Mice</category>

<category>Mitochondria</category>

<category>Mitochondrial Proteins</category>

<category>Neurons</category>

<category>Recombinant Fusion Proteins</category>

<category>X-Linked Inhibitor of Apoptosis Protein</category>

</item>






<item>
<title>Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation.</title>
<link>http://epubs.rcsi.ie/physiolart/15</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/15</guid>
<pubDate>Thu, 29 Sep 2011 08:12:18 PDT</pubDate>
<description>
	<![CDATA[
	<p>In the present study, we quantitatively analysed the interface between apoptosis initiation and execution by determining caspase-8 activation, Bid cleavage and mitochondrial engagement (onset of mitochondrial depolarisation) in individual HeLa cervical cancer cells following exposure to tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Employing resonance-energy-transfer probes containing either the caspase-8 recognition site IETD or full-length Bid, we observed a significant delay between the times of caspase-8 activation and Bid cleavage, suggesting the existence of control steps separating these two processes. Subsequent analyses suggested that the divergence of caspase-8 activation and Bid cleavage are critically controlled by kinase signalling: inhibiting protein kinase CK2 by using 5,6-dichloro-l-(beta-D-ribofuranosyl-1)-benzimidazole (DRB) or by overexpression of a dominant-negative CK2alpha catalytic subunit largely eliminated the lag time between caspase-8 activation and Bid cleavage. We conclude that caspase-8 activation and Bid cleavage are temporally uncoupled events, providing transient tolerance to caspase-8 activities.</p>

	]]>
</description>

<author>Christian T. Hellwig et al.</author>


<category>Apoptosis</category>

<category>BH3 Interacting Domain Death Agonist Protein</category>

<category>Casein Kinase II</category>

<category>Caspase 8</category>

<category>Enzyme Activation</category>

<category>Fluorescence Resonance Energy Transfer</category>

<category>Hela Cells</category>

<category>Humans</category>

<category>Kinetics</category>

<category>Protein Kinase Inhibitors</category>

<category>Protein Structure, Tertiary</category>

<category>Signal Transduction</category>

<category>Substrate Specificity</category>

<category>TNF-Related Apoptosis-Inducing Ligand</category>

<category>Time Factors</category>

</item>






<item>
<title>Elimination of water pathogens with solar radiation using and automated sequential batch CPC Reactor</title>
<link>http://epubs.rcsi.ie/physiolart/14</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/14</guid>
<pubDate>Thu, 18 Aug 2011 09:03:27 PDT</pubDate>
<description>
	<![CDATA[
	<p>Solar disinfection (SODIS) of water is well known, effective process which is practiced at household level in many developing countries. However, this process is limited by the small volume treated and the lack of indication of treatment efficacy. Low cost glass tube reactors together with compound parabolic collectors (CPC) technology, has been shown to significantly increase the efficiency of solar disinfection. However, these reactors still require user input to control each batch SODIS process and there is no feedback that the process is complete. Automatic operation of the batch SODIS process, controlled by UVA-radiation sensors, can provide information on the status of the process can ensure the required UVA dose to achieve complete disinfection received and reduces user work-load through automatic sequential batch processing. In this work, an enhanced CPC photo-reactor with a concentration factor of 1.89 was developed. The apparatus was fully automated to allow exposure to a threshold UVA dose, with treated water subsequently dispensed into a reservoir. The reactor was tested using <em>Escherichia coli</em> as a model pathogen in natural well water. A 6-log inactivation of <em>E. coli</em> was achieved following exposure to the minimum uninterrupted lethal UVA dose.  The enhanced reactor decreased the exposure time required to achieve the lethal UVA dose, in comparison to a CPC system with a concentration factor of 1.0. Doubling the lethal UVA dose prevented the need for a period of post exposure dark inactivation and therefore significantly reduced the overall SODIS treatment time.  Using this reactor, SODIS can be automatically carried out at an affordable cost, with reduced exposure time and minimal user input.</p>

	]]>
</description>

<author>M I. Polo-Lopez et al.</author>


</item>






<item>
<title>Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release.</title>
<link>http://epubs.rcsi.ie/physiolart/13</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/13</guid>
<pubDate>Mon, 15 Aug 2011 03:36:26 PDT</pubDate>
<description>
	<![CDATA[
	<p>Many anticancer drugs activate caspases via the mitochondrial apoptosis pathway. Activation of this pathway triggers a concomitant bioenergetic crisis caused by the release of cytochrome-c (cyt-c). Cancer cells are able to evade these processes by altering metabolic and caspase activation pathways. In this study, we provide the first integrated system study of mitochondrial bioenergetics and apoptosis signalling and examine the role of mitochondrial cyt-c release in these events. In accordance with single-cell experiments, our model showed that loss of cyt-c decreased mitochondrial respiration by 95% and depolarised mitochondrial membrane potential ΔΨ(m) from -142 to -88 mV, with active caspase-3 potentiating this decrease. ATP synthase was reversed under such conditions, consuming ATP and stabilising ΔΨ(m). However, the direction and level of ATP synthase activity showed significant heterogeneity in individual cancer cells, which the model explained by variations in (i) accessible cyt-c after release and (ii) the cell's glycolytic capacity. Our results provide a quantitative and mechanistic explanation for the protective role of enhanced glucose utilisation for cancer cells to avert the otherwise lethal bioenergetic crisis associated with apoptosis initiation.</p>

	]]>
</description>

<author>Heinrich J. Huber et al.</author>


<category>Adenosine Triphosphate</category>

<category>Apoptosis</category>

<category>Caspase 3</category>

<category>Cell Line</category>

<category>Cytochromes c</category>

<category>Energy Metabolism</category>

<category>Glucose</category>

<category>Hela Cells</category>

<category>Humans</category>

<category>Membrane Potential, Mitochondrial</category>

<category>Membrane Potentials</category>

<category>Mitochondria</category>

<category>Models, Theoretical</category>

</item>






<item>
<title>Diffusion is capable of translating anisotropic apoptosis initiation into a homogeneous execution of cell death.</title>
<link>http://epubs.rcsi.ie/physiolart/11</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/11</guid>
<pubDate>Thu, 05 May 2011 07:30:58 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>BACKGROUND:</strong> Apoptosis is an essential cell death process throughout the entire life span of all metazoans and its deregulation in humans has been implicated in many proliferative and degenerative diseases. Mitochondrial outer membrane permeabilisation (MOMP) and activation of effector caspases are key processes during apoptosis signalling. MOMP can be subject to spatial coordination in human cancer cells, resulting in intracellular waves of cytochrome-c release. To investigate the consequences of these spatial anisotropies in mitochondrial permeabilisation on subsequent effector caspase activation, we devised a mathematical reaction-diffusion model building on a set of partial differential equations.</p>
<p><strong>RESULTS: </strong>Reaction-diffusion modelling suggested that even if strong spatial anisotropies existed during mitochondrial cytochrome c release, these would be eliminated by free diffusion of the cytosolic proteins that instantiate the apoptosis execution network. Experimentally, rapid sampling of mitochondrial permeabilisation and effector caspase activity in individual HeLa cervical cancer cells confirmed predictions of the reaction-diffusion model and demonstrated that the signalling network of apoptosis execution could efficiently translate spatial anisotropies in mitochondrial permeabilisation into a homogeneous effector caspase response throughout the cytosol. Further systems modelling suggested that a more than 10,000-fold impaired diffusivity would be required to maintain spatial anisotropies as observed during mitochondrial permeabilisation until the time effector caspases become activated.</p>
<p><strong>CONCLUSIONS:</strong> Multi-protein diffusion efficiently contributes to eliminating spatial asynchronies which are present during the initiation of apoptosis execution and thereby ensures homogeneous apoptosis execution throughout the entire cell body. For previously reported biological scenarios in which effector caspase activity was shown to be targeted selectively to specific subcellular regions additional mechanisms must exist that limit or spatially coordinate caspase activation and/or protect diffusing soluble caspase substrates from unwanted proteolysis.</p>

	]]>
</description>

<author>Heinrich J. Huber et al.</author>


<category>Anisotropy</category>

<category>Apoptosis</category>

<category>Computer Simulation</category>

<category>Cytochromes c</category>

<category>Diffusion</category>

<category>Hela Cells</category>

<category>Humans</category>

<category>Mitochondria</category>

<category>Mitochondrial Proteins</category>

<category>Models, Biological</category>

<category>Signal Transduction</category>

</item>






<item>
<title>Expanding the substantial interactome of NEMO using protein microarrays.</title>
<link>http://epubs.rcsi.ie/physiolart/10</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/10</guid>
<pubDate>Mon, 24 Jan 2011 08:55:38 PST</pubDate>
<description>
	<![CDATA[
	<p>Signal transduction by the NF-kappaB pathway is a key regulator of a host of cellular responses to extracellular and intracellular messages. The NEMO adaptor protein lies at the top of this pathway and serves as a molecular conduit, connecting signals transmitted from upstream sensors to the downstream NF-kappaB transcription factor and subsequent gene activation. The position of NEMO within this pathway makes it an attractive target from which to search for new proteins that link NF-kappaB signaling to additional pathways and upstream effectors. In this work, we have used protein microarrays to identify novel NEMO interactors. A total of 112 protein interactors were identified, with the most statistically significant hit being the canonical NEMO interactor IKKbeta, with IKKalpha also being identified. Of the novel interactors, more than 30% were kinases, while at least 25% were involved in signal transduction. Binding of NEMO to several interactors, including CALB1, CDK2, SAG, SENP2 and SYT1, was confirmed using GST pulldown assays and coimmunoprecipitation, validating the initial screening approach. Overexpression of CALB1, CDK2 and SAG was found to stimulate transcriptional activation by NF-kappaB, while SYT1 overexpression repressed TNFalpha-dependent NF-kappaB transcriptional activation in human embryonic kidney cells. Corresponding with this finding, RNA silencing of CDK2, SAG and SENP2 reduced NF-kappaB transcriptional activation, supporting a positive role for these proteins in the NF-kappaB pathway. The identification of a host of new NEMO interactors opens up new research opportunities to improve understanding of this essential cell signaling pathway.</p>

	]]>
</description>

<author>Beau J. Fenner et al.</author>


<category>Base Sequence</category>

<category>Cell Line</category>

<category>DNA Primers</category>

<category>Humans</category>

<category>I-kappa B Kinase</category>

<category>NF-kappa B</category>

<category>Polymerase Chain Reaction</category>

<category>Protein Array Analysis</category>

<category>Protein Binding</category>

<category>Recombinant Proteins</category>

<category>Signal Transduction</category>

<category>Transcriptional Activation</category>

</item>






<item>
<title>INS-1 Cells Undergoing Caspase-Dependent Apoptosis Enhance the Regenerative Capacity of Neighbouring Cells</title>
<link>http://epubs.rcsi.ie/physiolart/9</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/9</guid>
<pubDate>Tue, 09 Nov 2010 07:55:44 PST</pubDate>
<description>
	<![CDATA[
	<p>Objective: In diabetes, beta cell mass is not static but in a constant process of cell death and renewal. Inactivating mutations in transcription factor 1 (tcf-1)/hepatocyte nuclear factor1a(hnf1a) result in decreased beta cell mass and HNF1A-maturity-onset-diabetes-of-the-young (HNF1A-MODY). Here we investigated the effect of a dominant-negative HNF-1A mutant (DNHNF1A) induced apoptosis on the regenerative capacity of INS-1 cells.  Research design and methods: DN-HNF1A was expressed in INS-1 cells using a reverse tetracycline-dependent transactivator system. Gene(s)/protein(s) involved in beta cell regeneration were investigated by real-time quantitative RT-PCR, Western blotting, and immunohistochemistry. Pancreatic stone protein/regenerating protein (PSP/reg) serum levels in human subjects were detected by ELISA.  Results: We detected a prominent induction of PSP/reg at gene and protein level during DNHNF1A- induced apoptosis. Elevated PSP/reg levels were also detected in islets of transgenic HNF1A-MODY mice and in the serum of HNF1A-MODY patients. The induction of PSP/reg was glucose dependent and mediated by caspase activation during apoptosis. Interestingly, the supernatant from DN-HNF1A-expressing cells, but not DN-HNF1A-expressing cells treated with zVADfmk, was sufficient to induce PSP/reg gene expression and increase cell proliferation in naïve, untreated INS-1 cells. Further experiments demonstrated that Annexin-V-positive microparticles (MPs) originating from apoptosing INS-1 cells mediated the induction of PSP/reg. Treatment with recombinant PSP/reg reversed the phenotype of DN-HNF1A-induced cells by stimulating cell proliferation and increasing insulin gene expression.  Conclusion: Our results suggest that apoptosing INS-1 cells shed microparticles that may stimulate PSP/reg induction in neighbouring cells, a mechanism that may facilitate the recovery of beta cell mass in HNF1A-MODY.</p>

	]]>
</description>

<author>Caroline Bonner et al.</author>


</item>






<item>
<title>Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents.</title>
<link>http://epubs.rcsi.ie/physiolart/8</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/8</guid>
<pubDate>Wed, 28 Apr 2010 03:03:07 PDT</pubDate>
<description>
	<![CDATA[
	<p>A novel bromide salt of the antidepressant bupropion (bupropion HBr) has recently been developed and approved for use in the United States. Given previous use of bromides to treat seizures, and that the existing chloride salt of bupropion (HCl) can cause seizures, it is important to determine if the HBr salt may be less likely to cause seizures than the HCl salt. In the present animal studies this was evaluated by means of quantified electroencephalogram (EEG), observation, and the rotarod test in mice and rats. Both bupropion salts were tested at increasing equimolar doses administered intraperitoneally. The results in mice showed that bupropion HCl 125 mg/kg induced a significantly higher ten-fold increase in the mean number of cortical EEG seizures compared to bupropion HBr (7.50 +/- 2.56 vs 0.75 +/- 0.96; p = 0.045), but neither drug caused any brain injuries. In rats bupropion HBr 100 mg/kg induced single EEG seizure activity in the cortical and hippocampal (depth) electrodes and in significantly (p < 0.05) fewer rats (44%) compared to bupropion HCl, which induced 1 to 4 convulsions per rat in all rats (100%) dosed. The total duration of cortical seizures in bupropion HCl-treated rats was significantly longer than the corresponding values obtained in bupropion HBr-treated rats (424.6 seconds vs 124.5 seconds respectively, p < 0.05). Bupropion HCl consistently induced more severe convulsions at each dose level compared to bupropion HBr. Both treatments demonstrated a similar dose-dependent impairment of rotarod performance in mice. In conclusion, these findings suggest that bupropion HBr may have a significantly lower potential to induce seizures in mice and rats, particularly at higher doses, compared to bupropion HCl. Determination of this potential clinical advantage will require human studies. If confirmed by such studies, it is likely that this potential beneficial clinical benefit would be due to the presence of the bromide salt given the long history of the use of bromide to treat seizure disorders.</p>

	]]>
</description>

<author>David C. Henshall et al.</author>


</item>






<item>
<title>Detection of 14-3-3zeta in cerebrospinal fluid following experimentally evoked seizures.</title>
<link>http://epubs.rcsi.ie/physiolart/7</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/7</guid>
<pubDate>Wed, 28 Apr 2010 02:15:55 PDT</pubDate>
<description>
	<![CDATA[
	<p>Surrogate and peripheral (bio)markers of neuronal injury may be of value in assessing effects of seizures on the brain or epilepsy development following trauma. The presence of 14-3-3 isoforms in cerebrospinal fluid (CSF) is a diagnostic indicator of Creutzfeldt-Jakob disease but these proteins may also be present following acute neurological insults. Here, we examined neuronal and 14-3-3 proteins in CSF from rats after seizures. Seizures induced by intra-amygdala microinjection of 0.1 microg kainic acid (KA) caused damage which was mainly restricted to the ipsilateral CA3 subfield of the hippocampus. 14-3-3zeta was detected at significant levels in CSF sampled 4 h after seizures compared with near absence in control CSF. Neuron-specific nuclear protein (NeuN) was also elevated in CSF in seizure rats. CSF 14-3-3zeta levels were significantly lower in rats treated with 0.01 microg KA. These data suggest the presence of 14-3-3zeta within CSF may be a biomarker of acute seizure damage.</p>

	]]>
</description>

<author>Niamh Murphy et al.</author>


<category>14-3-3 Proteins</category>

<category>Animals</category>

<category>Biological Markers</category>

<category>Hippocampus</category>

<category>Kainic Acid</category>

<category>Male</category>

<category>Nerve Tissue Proteins</category>

<category>Rats</category>

<category>Rats, Sprague-Dawley</category>

<category>Seizures</category>

</item>






<item>
<title>Angiogenin protects motoneurons against hypoxic injury.</title>
<link>http://epubs.rcsi.ie/physiolart/6</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/6</guid>
<pubDate>Thu, 01 Apr 2010 03:53:33 PDT</pubDate>
<description>
	<![CDATA[
	<p>Cells can adapt to hypoxia through the activation of hypoxia-inducible factor-1 (HIF-1), which in turn regulates the expression of hypoxia-responsive genes. Defects in hypoxic signaling have been suggested to underlie the degeneration of motoneurons in amyotrophic lateral sclerosis (ALS). We have recently identified mutations in the hypoxia-responsive gene, angiogenin (ANG), in ALS patients, and have shown that ANG is constitutively expressed in motoneurons. Here, we show that HIF-1alpha is sufficient and required to activate ANG in cultured motoneurons exposed to hypoxia, although ANG expression does not change in a transgenic ALS mouse model or in sporadic ALS patients. Administration of recombinant ANG or expression of wild-type ANG protected motoneurons against hypoxic injury, whereas gene silencing of ang1 significantly increased hypoxia-induced cell death. The previously reported ALS-associated ANG mutations (Q12L, K17I, R31K, C39W, K40I, I46V) all showed a reduced neuroprotective activity against hypoxic injury. Our data show that ANG plays an important role in endogenous protective pathways of motoneurons exposed to hypoxia, and suggest that loss of function rather than loss of expression of ANG is associated with ALS.</p>

	]]>
</description>

<author>J Sebastià et al.</author>


<category>Amino Acid Substitution</category>

<category>Amyotrophic Lateral Sclerosis</category>

<category>Animals</category>

<category>Apoptosis</category>

<category>Cell Hypoxia</category>

<category>Cells, Cultured</category>

<category>Hypoxia-Inducible Factor 1, alpha Subunit</category>

<category>Mice</category>

<category>Mice, Transgenic</category>

<category>Motor Neurons</category>

<category>Mutation</category>

<category>RNA, Small Interfering</category>

<category>Recombinant Proteins</category>

<category>Ribonuclease, Pancreatic</category>

<category>Signal Transduction</category>

<category>Vascular Endothelial Growth Factors</category>

</item>






<item>
<title>Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays.</title>
<link>http://epubs.rcsi.ie/physiolart/4</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/4</guid>
<pubDate>Thu, 25 Mar 2010 09:50:27 PDT</pubDate>
<description>
	<![CDATA[
	<p>Attachment of ubiquitin to proteins represents a central mechanism for the regulation of protein metabolism and function. In the NF-kappaB pathway, binding of NEMO to polyubiquitinated substrates initiates the pathway in response to cellular stimuli. Other polyubiquitin binding proteins can antagonize this pathway by competing with NEMO for polyubiquitin. We have used protein arrays to identify polyubiquitin binding proteins that regulate NF-kappaB activity. Using polyubiquitin as bait, protein arrays were screened and polyubiquitin binders identified. Novel polyubiquitin binders AWP1, CALCOCO2, N4BP1, RIO3, TEX27, TTC3, UBFD1 and ZNF313 were identified using this approach, while known NF-kappaB regulators including NEMO, A20, ABIN-1, ABIN-2, optineurin and p62 were also identified. Overexpressed AWP1 and RIO3 repressed NF-kappaB activity in a manner similar to optineurin, while siRNAs directed against AWP1 and RIO3 also reduced NF-kappaB activity. TNFalpha-dependent degradation of IkappaBalpha was also suppressed by overexpression of AWP1 and RIO3, possibly due to the polyubiquitin binding activity of these proteins. Protein array screening using polyubiquitin enabled rapid identification of many known and novel polyubiquitin binding proteins and the identification of novel NF-kappaB regulators.</p>

	]]>
</description>

<author>Beau J. Fenner et al.</author>


<category>Cell Line</category>

<category>Humans</category>

<category>NF-kappa B</category>

<category>Polyubiquitin</category>

<category>Protein Array Analysis</category>

<category>Proteins</category>

<category>Signal Transduction</category>

</item>






<item>
<title>Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review.</title>
<link>http://epubs.rcsi.ie/physiolart/3</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/3</guid>
<pubDate>Thu, 25 Mar 2010 09:37:10 PDT</pubDate>
<description>
	<![CDATA[
	<p>Colorectal cancer is a leading cause of cancer related mortality in the Western world. In recent years, combination 5-fluorouracil based adjuvant chemotherapy as first line treatment of this disease has led to improved disease free and overall survival. However drug resistance, both innate and acquired, remains an obstacle in the effective treatment of this disease. Apoptotic pathways are frequently altered in both tumor progression and drug resistance; therefore proteins associated with this pathway may have potential as prognostic biomarkers for this disease. Identification of clinical biomarkers that are able to identify patients who are more likely to respond to specific chemotherapy will lead to more personalized, effective, and less toxic therapy. This review focuses on the current status of apoptosis related proteins as biomarkers for colorectal cancer and discusses the possible application of systems approaches in this context.</p>

	]]>
</description>

<author>Suzanne Hector et al.</author>


<category>Animals</category>

<category>Apoptosis</category>

<category>Apoptotic Protease-Activating Factor 1</category>

<category>Autophagy</category>

<category>Caspases</category>

<category>Colorectal Neoplasms</category>

<category>Humans</category>

<category>Microtubule-Associated Proteins</category>

<category>Neoplasm Proteins</category>

<category>Prognosis</category>

<category>Proto-Oncogene Proteins c-bcl-2</category>

<category>Tumor Markers, Biological</category>

<category>bcl-2-Associated X Protein</category>

<category>bcl-X Protein</category>

</item>






<item>
<title>Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice.</title>
<link>http://epubs.rcsi.ie/physiolart/2</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/2</guid>
<pubDate>Thu, 25 Mar 2010 09:23:12 PDT</pubDate>
<description>
	<![CDATA[
	<p>Mesial temporal lobe epilepsy is the most common, intractable seizure disorder in adults. It is associated with an asymmetric pattern of hippocampal neuron loss within the endfolium (hilus and CA3) and CA1, with limited pathology in extra-hippocampal regions. We previously developed a model of focally-evoked seizure-induced neuronal death using intra-amygdala kainic acid (KA) microinjection and characterized the acute hippocampal pathology. Here, we sought to characterize the full extent of hippocampal and potential extra-hippocampal damage in this model, and the temporal onset of epileptic seizures. Seizure damage assessed at four stereotaxic levels by FluoroJade B staining was most prominent in ipsilateral hippocampal CA3 where it extended from septal to temporal pole. Minor but significant neuronal injury was present in ipsilateral CA1. Extra-hippocampal neuronal damage was generally limited in extent and restricted to the lateral septal nucleus, injected amygdala and select regions of neocortex ipsilateral to the seizure elicitation side. Continuous surface EEG recorded with implanted telemetry units in freely-moving mice detected spontaneous, epileptic seizures by five days post-KA in all mice. Epileptic seizure number averaged 1-4 per day. Hippocampi from epileptic mice 15 days post-KA displayed unilateral CA3 lesions, astrogliosis and increased neuropeptide Y immunoreactivity suggestive of mossy fiber rearrangement. These studies characterize a mouse model of unilateral hippocampal-dominant neuronal damage and short latency epileptogenesis that may be suitable for studying the cell and molecular pathogenesis of human mesial temporal lobe epilepsy.</p>

	]]>
</description>

<author>Genshin Mouri et al.</author>


<category>Amygdala</category>

<category>Animals</category>

<category>Cerebral Cortex</category>

<category>Disease Models, Animal</category>

<category>Electroencephalography</category>

<category>Epilepsy</category>

<category>Functional Laterality</category>

<category>Hippocampus</category>

<category>Kainic Acid</category>

<category>Male</category>

<category>Mice</category>

<category>Mice, Inbred C57BL</category>

<category>Microinjections</category>

<category>Nerve Tissue Proteins</category>

<category>Reaction Time</category>

<category>Statistics, Nonparametric</category>

<category>Time Factors</category>

</item>






<item>
<title>Dynamics of outer mitochondrial membrane permeabilization during apoptosis.</title>
<link>http://epubs.rcsi.ie/physiolart/1</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/physiolart/1</guid>
<pubDate>Thu, 25 Mar 2010 09:00:37 PDT</pubDate>
<description>
	<![CDATA[
	<p>Individual cells within a population undergo apoptosis at distinct, apparently random time points. By analyzing cellular mitotic history, we identified that sibling HeLa cell pairs, in contrast to random cell pairs, underwent apoptosis synchronously. This allowed us to use high-speed cellular imaging to investigate mitochondrial outer membrane permeabilization (MOMP), a highly coordinated, rapid process during apoptosis, at a temporal resolution approximately 100 times higher than possible previously. We obtained new functional and mechanistic insight into the process of MOMP: We were able to determine the kinetics of pore formation in the outer mitochondrial membrane from the initiation phase of cytochrome-c-GFP redistribution, and showed differential pore formation kinetics in response to intrinsic or extrinsic apoptotic stimuli (staurosporine, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)). We also detected that the onset of mitochondrial permeabilization frequently proceeded as a wave through the cytosol, and that the frequency of wave occurrence in response to TRAIL was reduced by inhibition of protein kinase CK2. Computational analysis by a partial differential equation model suggested that the spread of permeabilization signals could sufficiently be explained by diffusion-adsorption velocities of locally generated permeabilization inducers. Taken together, our study yielded the first comprehensive analysis of clonal cell-to-cell variability in apoptosis execution and allowed to visualize and explain the dynamics of MOMP in cells undergoing apoptosis.</p>

	]]>
</description>

<author>Markus Rehm et al.</author>


<category>Apoptosis</category>

<category>Cell Membrane Permeability</category>

<category>Cell Membrane Structures</category>

<category>Cytochromes c</category>

<category>Enzyme Inhibitors</category>

<category>Flow Cytometry</category>

<category>Hela Cells</category>

<category>Humans</category>

<category>Kinetics</category>

<category>Microscopy</category>

<category>Mitochondrial Membranes</category>

<category>Models, Biological</category>

<category>Staurosporine</category>

<category>TNF-Related Apoptosis-Inducing Ligand</category>

</item>





</channel>
</rss>
